RxDoctor Payments Data

Christopher Stalvey, DO

Pain Medicine · West Des Moines, IANPI 1891904660

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,850 of the $14,178 with a category attached, or 62.4%. 29 manufacturers reported payments, led by Nevro Corp. at 30.2% of the total. Reporting peaked in 2023 at $4,134 and has fallen 70.4% since, to $1,223 in 2025. Among pain medicine clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,178in general payments, 2019–2025

Across 394 payments — averaging $35.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$4K
  • Boston Scientific$3K
  • Si-bone, Inc.$2K
  • Abbott$1K
  • Nalu Medical, Inc.$482
  • AbbVie$399
  • plus $3K from 23 others
$3,600in research payments, 2019–2025

Across 2 payments — averaging $1800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$4K

What the payments were for

  • Speaking & faculty fees$1,90013%
  • Travel & lodging$3,42924%
  • Food & beverage$8,85062%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,178 in reported general payments places this provider in the 90th percentile of 31 pain medicine providers in Iowa.

See all pain medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$149,625
Medicare patients
200
Services billed
2,919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl11$5,191
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen131$2,758
Oxycodone Hcl52$1,266
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$622
Morphine Sulfate ErMorphine Sulfate16$555
Tramadol Hcl59$462
Acetaminophen-CodeineAcetaminophen With Codeine16$394
Pregabalin16$335
Hydromorphone Hcl29$313
Cephalexin35$243
Mupirocin37$227
Nabumetone13$152
RizatriptanRizatriptan Benzoate15$119
Promethazine Hcl12$109

Paid to pharmacies, not to this prescriber.

Other pain medicine in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →